FDA Approves First Drug Under New Fast-Track Review Program
-
LN24 / 3 weeks
- 0
- 2 min read
The U.S. Food and Drug Administration on Tuesday approved the first medication under its new fast-track initiative aimed at reducing the time needed to review drug applications. The antibiotic Augmentin XR received approval in just two months, a significant reduction from the typical 10-12 month review period. Augmentin XR, an oral combination of amoxicillin and clavulanate, is […]